A Novel Strategy to Rebalance Immunity in ITP – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia
In immune thrombocytopenia, tuning the enzymatic activity of CD38 restored regulatory T cell function through the deacetylase Sirt-1.
Working in patient cells and models, the authors show this approach rebalances immunity rather than broadly suppressing it, pointing to CD38 as a fresh therapeutic target that could explain durable responses in patients with ITP.”
Title: Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia
Authors: Mingfang Zhu, Haoyi Wang, Yitong Xu, Yubin Li, Wanru Wang, Lingjun Wang, Ruixue Wang, Ping Zhang, Ruting Wang, Junying Cao, Lin Wang, Yan Shi, Ming Hou, Yu Hou
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 27, 2026, 12:32Sonia Elena Popovici: Redefining Hemorrhagic Shock Through Cellular and Molecular Insights
-
Jul 27, 2026, 12:24Abdul Mannan: Why Quantitative FXIII Testing Matters
-
Jul 27, 2026, 12:13Ney Carter Borges: Biomechanics of Plaque Erosion in ACS
-
Jul 27, 2026, 12:05Irma Bagdoniene: The Silent Progression of Coronary Artery Disease
-
Jul 27, 2026, 11:45Ericka Robinson: Welcoming Vishakha K. Kumar to ISTH
-
Jul 27, 2026, 11:26ISTH Appoints a New CEO
-
Jul 27, 2026, 11:21Peter Bou Dib: How Lipocalin-2 Shapes the Immune Response After Stroke
-
Jul 27, 2026, 11:10Tareq Abadl: CSF Culture – Understanding Cerebrospinal Fluid Testing
-
Jul 27, 2026, 11:05Abdul Mannan: CTEPH – The Treatable Cause of Post-PE Breathlessness